Text Size

Cornell Translational Behavioral Science Research Consortium: Asthma Qualitative Study

This study has been completed.
Sponsor:
Information provided by:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT00195065
First received: September 13, 2005
Last updated: April 1, 2008
Last verified: April 2008
History of Changes
  Purpose

To explore and illuminate the cultural, social, and psychological factors that either facilitate or serve as barriers to behavioral change in asthma patients.


Condition Intervention
Asthma
 Behavioral: Semi-structured, open-ended interviews

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Cornell Translational Behavioral Science Research Consortium: Asthma Qualitative Study

Resource links provided by NLM:

MedlinePlus related topics: Asthma
U.S. FDA Resources

Further study details as provided by Weill Medical College of Cornell University:

Estimated Enrollment: 60
Study Start Date: April 2003
Estimated Study Completion Date: September 2003
Detailed Description:
  1. Through a series of open-ended questions we will explore and build a better understanding of how different patient populations view asthma and the difficulties they face in changing behavior. In addition the responses to such questions should help us to better understand and anticipate some of the barriers and issues that participants may face in successfully changing their behaviors.
  2. The second objective is to use the responses obtained to inform how an intervention of positive affect induction and self-affirmation should be operationalized and tailored.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Patients will be eligible for this study if their physicians consider them medically able to participate, if they are 18 years of age or older, and if they have a diagnosis of mild to moderate asthma based on the NHLBI Asthma Expert Panel's classification system which rates symptoms, frequency of exacerbations, nocturnal attacks, activity restriction, use of medications, and pulmonary function.

Exclusion Criteria:

Patients will be excluded from this study for the following reasons:

  • If they are unable to walk several blocks for whatever reason;
  • If they have musculoskeletal or neurological deficits that preclude increased physical activity;
  • If they have other pulmonary diseases;
  • If they have cardiac disease or other severe comorbidity;
  • If they are unable to provide informed consent because of cognitive deficits;
  • If they refuse to participate.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00195065

Locations
United States, New York
New York Presbyterian Hospital-Weill Medical College of Cornell University
New York, New York, United States, 10021
Sponsors and Collaborators
Weill Medical College of Cornell University
Investigators
Principal Investigator: Carol A Mancuso, MD Weill Medical College of Cornell University
Principal Investigator: Mary E Charlson, MD Weill Medical College of Cornell University
  More Information

Publications:

Responsible Party: Mary E. Charlson, MD, Weill Cornell Medical College
ClinicalTrials.gov Identifier: NCT00195065     History of Changes
Other Study ID Numbers: N01-HC-25196 (9811003566)
Study First Received: September 13, 2005
Last Updated: April 1, 2008
Health Authority: United States: Federal Government

Keywords provided by Weill Medical College of Cornell University:
Asthma
Behavior change
Physical activity
Risk reduction

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
 Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on May 16, 2013